Related Experiment Video
Updated: May 7, 2026

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
Published on: June 17, 2013
Norepinephrine transporter heterozygous knockout mice exhibit altered transport and behavior
H M Fentress1, R Klar, J J Krueger
1Division of Genetic Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.
Norepinephrine transporter (NET) heterozygous mice show reduced NET protein but compensated activity. Despite this, they exhibit anxiety and cognitive deficits, offering a model for human NET deficiency disorders.
Area of Science:
- Neuroscience
- Genetics
- Pharmacology
Background:
- The norepinephrine transporter (NET) is crucial for regulating norepinephrine (NE) in the brain and sympathetic nervous system.
- Genetic variations affecting NET expression are linked to psychiatric and cardiovascular conditions, but complete human deficiency is unknown.
- Existing NET knockout mouse models have limitations for studying genetically driven NET dysfunction.
Purpose of the Study:
- To investigate NET expression and function in NET heterozygous knockout male mice (NET(+/-)).
- To explore compensatory mechanisms for reduced NET protein levels.
- To assess the behavioral and physiological relevance of NET deficiency in a preclinical model.
Main Methods:
- Analysis of NET protein levels in NET(+/-) mice.
- Assessment of NET activity in hippocampal and cortical synaptosomes.
- Behavioral testing including open field, light-dark box, and Morris water maze for reversal learning.
- Evaluation of compensatory transport mechanisms (serotonin, dopamine, organic cation transporters).
Main Results:
- NET(+/-) mice exhibited approximately 50% reduction in NET protein levels.
- Despite reduced protein, NET activity in synaptosomes was not significantly impaired, suggesting functional compensation.
- Compensation was attributed to enhanced activity of existing surface NET transporters, not increased surface recruitment or alternative transporters.
- NET(+/-) mice displayed increased anxiety and deficits in reversal learning.
Conclusions:
- NET heterozygous mice present a novel model for studying NET deficiency and compensatory changes.
- Compensated NET activity in NET(+/-) mice is insufficient to prevent behavioral deficits, highlighting the importance of NET levels.
- This model offers insights into the behavioral and physiological consequences of NET dysfunction relevant to human disorders.
Related Concept Videos
Drugs Affecting Neurotransmitter Release or Uptake
Adrenergic Neurons: Neurotransmission
Synthesis: Catecholamine synthesis requires tyrosine, which...
Drugs Affecting Neurotransmitter Synthesis
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

